Intracochlear, biodegradable implants for controlled release of glucocorticoids

Background Effective local drug delivery to the inner ear is a major goal for efficient treatment of inner ear diseases. Direct intracochlear drug application would overcome disadvantages of systemic and intratympanic treatment i.e., effects of the blood-labyrinth and the round window membrane barrier.